Ground News

News from NewMediaWire

See all of NewMediaWire’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

Ground News has come across 345 headlines reported on by NewMediaWire during the past 3 months.

The Ground News media bias check for NewMediaWire is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

NewMediaWire’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about NewMediaWire

Where is NewMediaWire located?NewMediaWire's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top NewMediaWire News

Philadelphia, Pennsylvania · Philadelphia

Bragar Eagel & Squire_ P.C. Reminds Investors That Class Action Lawsuits Have Been Filed

71% Center coverage: 14 sources

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE)See the Story

Health

DEADLINE ALERT for RDDT and HIMS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

75% Center coverage: 4 sources

Open the article to view the coverage from Benzinga See the Story

Pharma

Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test

100% Center coverage: 3 sources

Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma. The post Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test appeared first on MedCity News.See the Story

Law Firm Sues Michael Saylor's Strategy Over Misleading Bitcoin Claims

100% Center coverage: 2 sources

A new class action lawsuit, filed in the Eastern District of Virginia, accuses the Bitcoin-heavy firm and its executives of […] The post Massive Bitcoin Loss Triggers Legal Firestorm Against Strategy appeared first on Coindoo.Tweet · Virginia See the Story

FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline

100% Left coverage: 1 sources

LOS ANGELES, July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ: FTRE) for violations of the federal securities laws.Los Angeles, California · Los Angeles See the Story

Metavesco Completes Significant Share Buyback to Enhance Shareholder Value

Metavesco, Inc. (OTC: MVCO), a diversified holding company, has announced the completion of a buyback of 200 million shares of its common stock, marking a significant step in its strategy to enhance shareholder value. The repurchased shares are set to be returned to the treasury for cancellation, reducing the company’s issued and outstanding common stock by over 5%. This decision underscores the company’s commitment to improving per-share metric…See the Story

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Sarepta Therapeutics, Inc. Lawsuit

100% Center coverage: 1 sources

Open the article to view the coverage from NewMediaWire See the Story

Vestis Corporation Class Action: Levi & Korsinsky Reminds Vestis Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 8, 2025

Open the article to view the coverage from NewMediaWire Read Article

Contact Levi & Korsinsky by July 21, 2025 Deadline to Join Class Action Against DoubleVerify Holdings, Inc. (DV)

Open the article to view the coverage from NewMediaWire Read Article

Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Seeking Recovery for Investors - Contact Levi & Korsinsky

Open the article to view the coverage from NewMediaWire Read Article

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Reckitt Benckiser Group plc (RBGLY) Shareholders

Open the article to view the coverage from NewMediaWireSlough · Slough Read Article

News from NewMediaWire

News from NewMediaWire

Information about NewMediaWire

Media Bias Ratings

Factuality

Ownership

Top NewMediaWire News

Bragar Eagel & Squire_ P.C. Reminds Investors That Class Action Lawsuits Have Been Filed

DEADLINE ALERT for RDDT and HIMS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test

Law Firm Sues Michael Saylor's Strategy Over Misleading Bitcoin Claims

FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline

Metavesco Completes Significant Share Buyback to Enhance Shareholder Value

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Sarepta Therapeutics, Inc. Lawsuit

Vestis Corporation Class Action: Levi & Korsinsky Reminds Vestis Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 8, 2025

Contact Levi & Korsinsky by July 21, 2025 Deadline to Join Class Action Against DoubleVerify Holdings, Inc. (DV)

Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Seeking Recovery for Investors - Contact Levi & Korsinsky

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Reckitt Benckiser Group plc (RBGLY) Shareholders

Similar News Topics

Topics Most Covered by NewMediaWire

Sources Covering Similar Topics

Breaking News Topics Related to NewMediaWire